InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Arnold Susan Elizabeth, Vice-Président. Director active across 2 companies, notably PhaseBio Pharmaceuticals Inc. Cumulatively, 9 reports have been published. The latest transaction was disclosed on 20 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations9 total
€7,03110,917 shares@ €0.64410.5% of flow
Common Stock
SEC:0001169245-22-000079:0·
€4,5242,559 shares@ €1.768115.2% of flow
Common Stock
SEC:0001169245-21-000128·
€4,5242,559 shares@ €1.76816.8% of flow
Common Stock
SEC:0001169245-21-000128:0·
€6,6274,519 shares@ €1.466522.2% of flow
Common Stock
SEC:0001169245-21-000089·
€6,6274,519 shares@ €1.46659.9% of flow
Common Stock
SEC:0001169245-21-000089:0·
€6,6274,519 shares@ €1.466522.2% of flow
Common Stock
SEC:0001169245-21-000069·
€6,6274,519 shares@ €1.46659.9% of flow
Common Stock
SEC:0001169245-21-000069:0·
€12,0405,257 shares@ €2.290340.4% of flow
Common Stock
SEC:0001169245-21-000043·
€12,0405,257 shares@ €2.290318.1% of flow
Common Stock
SEC:0001169245-21-000043:0·
9 of 9 declarations
About Arnold Susan Elizabeth
Susan Elizabeth Arnold is Vice President of Preclinical and Chemistry, as well as Senior Vice President of Technical Operations at PhaseBio Pharmaceuticals Inc. She plays a key role in product development and optimizing technical operations. Her expertise contributes to the innovation and growth of the company.
